Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease
Identifieur interne : 004661 ( Main/Exploration ); précédent : 004660; suivant : 004662Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease
Auteurs : O. Rascol [France] ; A. J. Lees ; J. M. Senard [France] ; Z. Pirtosek ; J. L. Montastruc [France] ; D. FuellSource :
- Clinical neuropharmacology [ 0362-5664 ] ; 1996.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adult, Aged, Agonist, Aminoacid, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Chemotherapy, D2 Dopamine receptor, Dopa, Dopamine Agonists (administration & dosage), Dopamine Agonists (adverse effects), Double-Blind Method, Drug Therapy, Combination, Drug combination, Drug interaction, Female, Human, Humans, Indoles (administration & dosage), Indoles (adverse effects), Levodopa (administration & dosage), Levodopa (therapeutic use), Male, Middle Aged, Motor Activity (drug effects), Oral administration, Parkinson Disease (drug therapy), Parkinson disease, Placebo, Treatment efficiency.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Dopamine Agonists, Indoles, Levodopa.
- chemical , adverse effects : Dopamine Agonists, Indoles.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- drug effects : Motor Activity.
- drug therapy : Parkinson Disease.
- Adult, Aged, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001803
- to stream PascalFrancis, to step Curation: 001843
- to stream PascalFrancis, to step Checkpoint: 001636
- to stream Main, to step Merge: 004F32
- to stream PubMed, to step Corpus: 001574
- to stream PubMed, to step Curation: 001533
- to stream PubMed, to step Checkpoint: 001533
- to stream Ncbi, to step Merge: 001E09
- to stream Ncbi, to step Curation: 001E09
- to stream Ncbi, to step Checkpoint: 001E09
- to stream Main, to step Merge: 004D21
- to stream Main, to step Curation: 004661
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease</title>
<author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O." last="Rascol">O. Rascol</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">A. J. Lees</name>
</author>
<author><name sortKey="Senard, J M" sort="Senard, J M" uniqKey="Senard J" first="J. M." last="Senard">J. M. Senard</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pirtosek, Z" sort="Pirtosek, Z" uniqKey="Pirtosek Z" first="Z." last="Pirtosek">Z. Pirtosek</name>
</author>
<author><name sortKey="Montastruc, J L" sort="Montastruc, J L" uniqKey="Montastruc J" first="J. L." last="Montastruc">J. L. Montastruc</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fuell, D" sort="Fuell, D" uniqKey="Fuell D" first="D." last="Fuell">D. Fuell</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">96-0305270</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0305270 INIST</idno>
<idno type="RBID">Pascal:96-0305270</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001803</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001843</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001636</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001636</idno>
<idno type="wicri:doubleKey">0362-5664:1996:Rascol O:ropinirole:in:the</idno>
<idno type="wicri:Area/Main/Merge">004F32</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8726542</idno>
<idno type="wicri:Area/PubMed/Corpus">001574</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001574</idno>
<idno type="wicri:Area/PubMed/Curation">001533</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001533</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001533</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001533</idno>
<idno type="wicri:Area/Ncbi/Merge">001E09</idno>
<idno type="wicri:Area/Ncbi/Curation">001E09</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001E09</idno>
<idno type="wicri:doubleKey">0362-5664:1996:Rascol O:ropinirole:in:the</idno>
<idno type="wicri:Area/Main/Merge">004D21</idno>
<idno type="wicri:Area/Main/Curation">004661</idno>
<idno type="wicri:Area/Main/Exploration">004661</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease</title>
<author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O." last="Rascol">O. Rascol</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">A. J. Lees</name>
</author>
<author><name sortKey="Senard, J M" sort="Senard, J M" uniqKey="Senard J" first="J. M." last="Senard">J. M. Senard</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pirtosek, Z" sort="Pirtosek, Z" uniqKey="Pirtosek Z" first="Z." last="Pirtosek">Z. Pirtosek</name>
</author>
<author><name sortKey="Montastruc, J L" sort="Montastruc, J L" uniqKey="Montastruc J" first="J. L." last="Montastruc">J. L. Montastruc</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fuell, D" sort="Fuell, D" uniqKey="Fuell D" first="D." last="Fuell">D. Fuell</name>
</author>
</analytic>
<series><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Agonist</term>
<term>Aminoacid</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>D2 Dopamine receptor</term>
<term>Dopa</term>
<term>Dopamine Agonists (administration & dosage)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Drug combination</term>
<term>Drug interaction</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Indoles (administration & dosage)</term>
<term>Indoles (adverse effects)</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Activity (drug effects)</term>
<term>Oral administration</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Placebo</term>
<term>Treatment efficiency</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Indoles</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term>
<term>Indoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Ropinirole</term>
<term>Agoniste</term>
<term>Dopa</term>
<term>Parkinson maladie</term>
<term>Récepteur dopaminergique D2</term>
<term>Antiparkinsonien</term>
<term>Homme</term>
<term>Chimiothérapie</term>
<term>Efficacité traitement</term>
<term>Association médicamenteuse</term>
<term>Interaction médicamenteuse</term>
<term>Voie orale</term>
<term>Placebo</term>
<term>Aminoacide</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement><li>Toulouse</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Fuell, D" sort="Fuell, D" uniqKey="Fuell D" first="D." last="Fuell">D. Fuell</name>
<name sortKey="Lees, A J" sort="Lees, A J" uniqKey="Lees A" first="A. J." last="Lees">A. J. Lees</name>
<name sortKey="Pirtosek, Z" sort="Pirtosek, Z" uniqKey="Pirtosek Z" first="Z." last="Pirtosek">Z. Pirtosek</name>
</noCountry>
<country name="France"><region name="Occitanie (région administrative)"><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O." last="Rascol">O. Rascol</name>
</region>
<name sortKey="Montastruc, J L" sort="Montastruc, J L" uniqKey="Montastruc J" first="J. L." last="Montastruc">J. L. Montastruc</name>
<name sortKey="Senard, J M" sort="Senard, J M" uniqKey="Senard J" first="J. M." last="Senard">J. M. Senard</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004661 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004661 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:96-0305270 |texte= Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |